Laird Norton Wetherby Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,133
Closed -$208K – 967
2024
Q1
$208K Buy
+1,133
New +$216K 0.01% 874
2022
Q1
– Sell
-1,012
Closed -$268K – 964
2021
Q4
$268K Buy
1,012
+35
+4% +$9.43K 0.02% 761
2021
Q3
$282K Buy
+977
New +$251K 0.02% 732
2021
Q2
– Sell
-1,065
Closed -$207K – 942
2021
Q1
$207K Buy
+1,065
New +$218K 0.02% 733

Other funds holding RGEN

Laird Norton Wetherby Wealth Management's RGEN Position: Q2 2024 in Review

Laird Norton Wetherby Wealth Management sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,133 shares — an estimated $208K sold.

Laird Norton Wetherby Wealth Management first reported a position in RGEN in Q1 2021 and held it in 4 quarters. The position peaked at $282K in Q3 2021. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Laird Norton Wetherby Wealth Management reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 1,133 Repligen shares in Q2 2024, an estimated $208K.
  • Laird Norton Wetherby Wealth Management first reported a position in Repligen in Q1 2021 and held it in 4 quarters.
  • Laird Norton Wetherby Wealth Management's Repligen position peaked at $282K in Q3 2021.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.